Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ghrelin in anterior circulation stroke and EVT
2022-001632-28Phase 2Active
- Sponsor
- Rijnstate
- Start
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of human ghrelin in ischemic stroke, sponsored by Rijnstate. Primary endpoint: Neurological deficit at 7 days. Started Apr 2023; status: active.
02
Drugs
human ghrelin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2022-001632-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001632-28.